{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal UMC119-01",
            "NStudiesAvail": 430108,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "ResultsFirstSubmitDate",
                  "ResultsFirstSubmitQCDate",
                  "RetractionPMID",
                  "RetractionSource",
                  "SamplingMethod",
                  "SecondaryId",
                  "SecondaryIdDomain",
                  "SecondaryIdLink",
                  "SecondaryIdType",
                  "SecondaryOutcomeDescription",
                  "SecondaryOutcomeMeasure",
                  "SecondaryOutcomeTimeFrame",
                  "SeeAlsoLinkLabel",
                  "SeeAlsoLinkURL",
                  "SeriousEventAssessmentType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "The percentage of subjects who died from any cause during the study.",
                              "Changes from baseline of the oxygen saturation.",
                              "Changes from baseline to 3 months of chest x-ray findings in participants before and after administration.",
                              "Changes from baseline of inflammatory markers (pg/ml) .",
                              "Comparison of the incidence and severity of preterm children's complications in participants before and after administration.",
                              "The number of days of intubation, or where ventilator or oxygen therapy.",
                              "Incidence of moderate/severe BPD or death at 36 weeks postmenstrual age (PMA)."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "The percentage of subjects who died from any cause during the study.",
                              "Changes of the oxygen saturation.",
                              "Changes of chest x-ray findings in participants before and after administration.",
                              "Changes of inflammatory markers (pg/ml) before and after administration.",
                              "Comparison of the incidence and severity of preterm children's complications in participants before and after administration.",
                              "The number of days of intubation, or where ventilator or oxygen therapy.",
                              "Incidence of moderate/severe BPD or death at 36 weeks postmenstrual age (PMA)."
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "3 months from the day of administration",
                              "3 months from the day of administration",
                              "3 months from the day of administration",
                              "3 days and 7 days after administration",
                              "3 months from the day of administration",
                              "3 months from the day of administration",
                              "36 weeks postmenstrual age (PMA)"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03631420"
                        ]
                  }
            ]
      }
}